Regulatory mechanisms, including inhibition by IκBs, ubiquitination, deubiquitinases (DUBs), negative feedback, and regulation of NIK and the IKK complex, ensure strict control of NF-κB pathways to prevent chronic inflammation, cancer, and autoimmune diseases [17]. The gene discussed is NFKB1; the disease is cancer.